Panaxia Labs Israel Ltd
TASE:PNAX
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
PNAX's latest stock split occurred on Mar 17, 2024
The company executed a 1-for-100 stock split, meaning that for every 100 shares held, investors received 1 new share.
Before the split, PNAX traded at 10390 per share. Afterward, the share price was about 10390.
The adjusted shares began trading on Mar 17, 2024. This was PNAX's 2nd stock split, following the previous one in Jan 29, 2023.
Global
Stock Splits Monitor
| Date | Company | Split | Pre-Split Price | Post-Split Price | |
|---|---|---|---|---|---|
|
Apr 27, 2026
|
M
|
Mitsubishi Logisnext Co Ltd
TSE:7105
|
1-for-22962728
/22962728
|
1529 999999.9999 JPY | N/A |
|
Apr 27, 2026
|
|
Intsig Information Co Ltd
SSE:688615
|
1-for-1
x1
|
180.14 127.0214 CNY | 128 128 CNY |
|
Apr 27, 2026
|
|
Nousouken Corp
TSE:3541
|
1-for-550000
/550000
|
763 763 JPY | N/A |
|
Apr 27, 2026
|
F
|
Friendly Corp
TSE:8209
|
1-for-1355800
/1355800
|
312 999999.9999 JPY | N/A |
|
Apr 27, 2026
|
I
|
IA Inc
KOSDAQ:038880
|
1-for-10
/10
|
135 1350 KRW | 1231 1231 KRW |
688615
3541
Panaxia Labs Israel Ltd
Glance View
Panaxia Labs Israel Ltd. engages in the manufacture and distribution of medical cannabis products. The firm provides pharma-grade smokeless cannabis products that provide better delivery systems for patients and physicians when properly assessing safety and dosage. Panaxia pharmaceutical cannabis products are specifically tailored to meet a broad range of needs. It's product portfolio includes: NAXIVA-PANAXOL Advanced kit for preparation of cannabis oil-standardized extract, NAXIVA-PANAXOL Purified extract for inhalation, PANAXIR Medical Cannabis Orodispersible Tablets, PANAXIR SENSE Orange Creamsicle Medical cannabis sublingual drops, PANAXIR CBD Melatonin Tablets, PANAXIR Medical cannabis extracts in ethanol among others.
